Lot #2657261

RECONSTITUTION SOLUTION [10ml]

4.9 / 5

Trusted by 5,000+ researchers

10ml / vial

≥99% HPLC

Bacteriostatic water

Pharmaceutical-Grade Peptide Reconstitution Solvent

RECONSTITUTION SOLUTION [10ml]

10ml / vial

Bacteriostatic water

≥99% HPLC

4.9 / 5

Trusted by 5,000+ researchers

$12.00

30-day money back

2-day shipping

Signed COA on every batch

Secure checkout

Research use only · Not for human or veterinary use

COA on Every Batch

BioRegen Verified

≥99% HPLC Purity

Made in the USA

2-Day Shipping

30-Day Money Back

Compound Profile

Bacteriostatic Water for Injection (BWFI)

Bacteriostatic Water for Injection (BWFI) is a sterile, non-pyrogenic aqueous preparation containing 0.9% benzyl alcohol (9 mg/mL) as a bacteriostatic preservative, prepared in accordance with United States Pharmacopeia (USP) standards. The 0.9% benzyl alcohol concentration inhibits microbial growth, enabling multi-dose use of reconstituted research solutions when stored under appropriate conditions. BWFI is the standard diluent for reconstituting lyophilized peptide research compounds prior to experimental use. Each vial is sterility-tested and endotoxin-screened.

Bacteriostatic Water for Injection (BWFI) is a pharmaceutical-grade solvent standardized under USP and screened for sterility per USP and endotoxin per USP . The 0.9% benzyl alcohol preservative provides antimicrobial protection through membrane disruption of microbial cells. For peptide reconstitution research, BWFI is preferred over plain sterile water because it extends the usable life of reconstituted solutions when stored refrigerated (2-8°C) and used within 28 days. Research compounds should be reconstituted by injecting BWFI along the vial wall, gently swirling (never vortexing), and allowing complete dissolution before use.

Documented Research Areas

  • Bacteriostatic preservation via 0.9% benzyl alcohol (w/v) per USP specification
  • Sterility tested per USP <71> — membrane filtration and direct inoculation methods
  • Endotoxin burden tested via LAL assay per USP <85>
  • Compatible with lyophilized peptide solubility and stability profiles
  • Multi-dose septum vial rated for repeated needle access without coring
  • pH 4.5–7.0 compatible with standard 1ml insulin syringe reconstitution protocols

For research use only. Statements above describe published research literature and do not constitute health, medical, or therapeutic claims for either compound or for the blend. Not for human or veterinary use. Not evaluated by the FDA.

Compound Profile

Bacteriostatic Water for Injection (BWFI)

Bacteriostatic Water for Injection (BWFI) is a sterile, non-pyrogenic aqueous preparation containing 0.9% benzyl alcohol (9 mg/mL) as a bacteriostatic preservative, prepared in accordance with United States Pharmacopeia (USP) standards. The 0.9% benzyl alcohol concentration inhibits microbial growth, enabling multi-dose use of reconstituted research solutions when stored under appropriate conditions. BWFI is the standard diluent for reconstituting lyophilized peptide research compounds prior to experimental use. Each vial is sterility-tested and endotoxin-screened.

— Component 01
Bacteriostatic Water · 10ml
Class
Sterile bacteriostatic water for injection (BWFI)
Sequence
Non-peptide pharmaceutical solvent — 0.9% benzyl alcohol in sterile water
CAS Number
7732-18-5 (water) / 100-51-6 (benzyl alcohol)
Molecular Formula
H₂O / C₇H₈O
Molecular Weight
18.02 / 108.14 g/mol
Per-component purity
USP Grade
Form
Sterile aqueous solution, multi-dose vial
Identity (LC-MS)
All confirmed
Sterility / LAL
PASS
Storage
15-25°C (room temp), sealed, dry
Origin
Made in the USA
In the Literature

Reconstitution Reference

Bacteriostatic Water for Injection (BWFI) is a pharmaceutical-grade solvent standardized under USP and screened for sterility per USP and endotoxin per USP . The 0.9% benzyl alcohol preservative provides antimicrobial protection through membrane disruption of microbial cells. For peptide reconstitution research, BWFI is preferred over plain sterile water because it extends the usable life of reconstituted solutions when stored refrigerated (2-8°C) and used within 28 days. Research compounds should be reconstituted by injecting BWFI along the vial wall, gently swirling (never vortexing), and allowing complete dissolution before use.

For research use only. Statements above describe published research literature and do not constitute health, medical, or therapeutic claims for either compound or for the blend. Not for human or veterinary use. Not evaluated by the FDA.

Documented Research Areas

  • Bacteriostatic preservation via 0.9% benzyl alcohol (w/v) per USP specification
  • Sterility tested per USP <71> — membrane filtration and direct inoculation methods
  • Endotoxin burden tested via LAL assay per USP <85>
  • Compatible with lyophilized peptide solubility and stability profiles
  • Multi-dose septum vial rated for repeated needle access without coring
  • pH 4.5–7.0 compatible with standard 1ml insulin syringe reconstitution protocols

Selected Studies · Peer-Reviewed Literature

A curated list of published peer-reviewed papers indexed in PubMed where BPC-157 has been studied. Provided for research-context only. Linking to the literature does not constitute endorsement of any therapeutic application.

Compound database reference for chemical and structural data:

Research You Can Trust.

At Revvd Research, quality comes first. Our peptides are produced using advanced manufacturing processes and verified through comprehensive testing protocols to deliver dependable results for research applications.

Verified Purity
0 %+
Quality Assured
0 %

USA

Produced

Transparency

Every lot. Every researcher. Same proof.

Each batch ships with a third-party Certificate of Analysis from BioRegen Analytical. HPLC purity, mass-spectrometry identity, sterility, and LAL endotoxin screening. Every test, every lot.

Your lot number ships on the label and on the COA. Enter it in the verifier any time to retrieve the original lab report.

Verify Batch COA

Certificate of Analysis

ProductBacteriostatic Water for Injection (BWFI)
Preservative0.9% Benzyl Alcohol (w/v) · CAS 100-51-6
SolventSterile Water for Injection · CAS 7732-18-5
Volume10ml / vial
pH4.5–7.0
Sterility (USP <71>)PASS
Endotoxin (LAL)PASS
Date TestedOn file

Pairs With

Related compounds.

Other research peptides in the Revvd catalog cited alongside the BPC-157 + TB-500 blend in the published research literature.

1

GLOW [70mg]

50mg / 10mg / 10mg per vial

CAS#

49557-75-7

Formula

C₁₄H₂₄CuN₆O₄

M.W.

403.9 g/mol
Research use only · Not for human or veterinary use

$80.00

$160
2

BPC-157 [10mg]

10mg / vial

CAS#

137525-51-0

Formula

C₆₂H₉₈N₁₆O₂₂

M.W.

1,419.55 g/mol
Research use only · Not for human or veterinary use

$40.00

$80
3

BPC-157 + TB-500 [5mg/5mg]

5mg / 5mg per vial

CAS#

137525-51-0

Formula

C₆₂H₉₈N₁₆O₂₂

M.W.

1,419.55 g/mol
Research use only · Not for human or veterinary use

$47.50

$95
4

TESAMORELIN + IPAMORELIN [5mg/5mg]

5mg / 5mg per vial

CAS#

218949-48-5

Formula

C₂₂₁H₃₆₆N₇₂O₆₇S

M.W.

5,135.77 g/mol
Research use only · Not for human or veterinary use

$55.00

$110
Common Reviews

Write Reviews Here

[wiserrw_product_review]
Common Questions

Answered straight.

The standard for research integrity.

Featured Collection – Premium purity compounds crafted with consistency, precision, and quality in mind.

Ready to Order

Add the RECONSTITUTION SOLUTION [10ml] blend to your research arsenal.

5,000+ researchers trust Revvd for batch-tested peptides. Every vial. Every COA. Every time.

30-day money back · Free shipping over $150 · 2-day shipping

Signed COA on every batch